Vistagen Therapeutics (VTGN) Long-Term Debt Repayments (2010 - 2026)
Vistagen Therapeutics (VTGN) reported Long-Term Debt Repayments of $96,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 6.7% from $90,000 a year earlier but down 66.1% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Long-Term Debt Repayments (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vistagen Therapeutics' Long-Term Debt Repayments came in at $931,000, up 934.4% year-over-year; for FY2026 (ended Mar 31, 2026), it was $925,000.
- Long-Term Debt Repayments has a five-year compound annual growth rate of 8.9% (FY2021 to FY2026).
- By fiscal year, Long-Term Debt Repayments came in at $985,000 in FY2024 (-4.7%), $1.03 million in FY2023 and $3,000 in FY2022 (-99.5%).
- Five-year quarterly Long-Term Debt Repayments spans a low of -$1,000 in fiscal Q3 2024 and a high of $785,000 in fiscal Q2 2024.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $283,000 (Q4 2026), $278,000 (Q3 2026) and $274,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.00 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -2.45 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 17.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - | 96,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96,000.00 |
| Mar 31, 2026 | 283,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Jun 30, 2025 | 90,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 785,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Mar 31, 2023 | 313,500.00 |
| Dec 31, 2022 | 310,800.00 |
| Sep 30, 2022 | 307,800.00 |
| Jun 30, 2022 | 101,900.00 |
| Mar 31, 2022 | 200.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 900.00 |
| Jun 30, 2021 | 900.00 |
| Mar 31, 2021 | 98,500.00 |
| Dec 31, 2020 | 340,500.00 |
| Sep 30, 2020 | 114,200.00 |
| Jun 30, 2020 | 49,900.00 |
API Access
Vistagen Therapeutics Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();